Explore

Why Sunscreen Standards Aren't the Same Everywhere

Why Sunscreen Standards Aren't the Same Everywhere

Sunscreen regulations vary significantly across the globe, reflecting different approaches to safety, efficacy, and environmental impact. Understan...

What Makes Some Sunscreens Better at Blocking UV Rays?

What Makes Some Sunscreens Better at Blocking UV Rays?

Sunscreening agents play a crucial role in protecting our skin from the harmful effects of ultraviolet (UV) radiation. These agents are found in va...

The Science Behind How Sunscreen Works

The Science Behind How Sunscreen Works

Oxybenzone is a key ingredient in many sunscreen products, known for its ability to absorb ultraviolet (UV) radiation and protect the skin from sun...

Experts Advise Against Mixing Self-Tan and SPF to Ensure Effective Sun Protection

Experts Advise Against Mixing Self-Tan and SPF to Ensure Effective Sun Protection

Experts Advise Against Mixing Self-Tan and SPF to Ensure Effective Sun Protection

FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers

FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers

Federal health advisers are meeting to review a group of controversial chemicals called peptides

FDA Panel Recommends Easing Restrictions on Unapproved Peptides Despite Safety Concerns

FDA Panel Recommends Easing Restrictions on Unapproved Peptides Despite Safety Concerns

A panel of federal health advisers has recommended that the Food and Drug Administration (FDA) ease restrictions on several peptides, including BPC-157, TB-500, and KPV. These peptides are popular among wellness influencers and celebrities, despite warnings from FDA scientists about their safety and efficacy. The panel's decision, which is not binding, suggests adding these peptides to the FDA's list of substances considered safe for pharmacy compounding. This move could lead to increased marketing of these chemicals for wellness and cosmetic uses. The panel's vote was close, with an 8-6 outcome and one abstention, reflecting the panel's unusual composition, which included several members with ties to the peptide industry.

FDA to Review Peptide Regulations Amid Safety Concerns

FDA to Review Peptide Regulations Amid Safety Concerns

The U.S. Food and Drug Administration (FDA) is set to convene a panel of outside experts to discuss whether compounding pharmacies should be allowed to produce certain injectable peptides. These peptides, including TB-500, BPC-157, and MOTs-C, are popular in the wellness industry for their purported benefits in muscle growth, fat loss, and skin health. However, none of these compounds have undergone large-scale trials to establish their safety and efficacy, raising concerns among scientists and regulators. The FDA's Pharmacy Compounding Advisory Committee will review the evidence for these peptides over a two-day meeting. The discussion comes amid a growing demand for peptides, which has led to a gray market of unregulated suppliers.

FDA reviews peptide injections favored by RFK Jr. and wellness influencers

FDA reviews peptide injections favored by RFK Jr. and wellness influencers

Federal health advisers are meeting to review a group of controversial chemicals called peptides

FDA to Review Controversial Peptides Amid Rising Popularity and Safety Concerns

FDA to Review Controversial Peptides Amid Rising Popularity and Safety Concerns

The U.S. Food and Drug Administration (FDA) is set to review the safety and efficacy of seven peptides that have gained popularity for their purported health benefits, such as muscle growth and anti-aging. These compounds have been promoted by social media influencers and endorsed by Health Secretary Robert F. Kennedy Jr. Despite their popularity, the FDA has raised concerns about the lack of evidence supporting their safety and effectiveness. The review will determine whether these peptides can be made available through licensed pharmacies, potentially impacting their regulation and availability.

FDA panel narrowly backs unapproved peptide drugs favored by RFK Jr. and wellness influencers

FDA panel narrowly backs unapproved peptide drugs favored by RFK Jr. and wellness influencers

Federal health advisers are recommending broader access to controversial chemicals called peptides

Dermatologists Highlight Importance of SPF Even Under Clothing

Dermatologists Highlight Importance of SPF Even Under Clothing

Dermatologists Highlight Importance of SPF Even Under Clothing

FDA Advisory Committee to Review Peptide Regulations in the U.S.

FDA Advisory Committee to Review Peptide Regulations in the U.S.

The U.S. Food and Drug Administration's Pharmacy Compounding Advisory Committee is set to meet to discuss the regulation of certain peptides, which are popular in wellness circles for their purported health benefits. The committee will consider whether compounding pharmacies should be allowed to dispense these peptides, which are not currently FDA-approved. The meeting is significant as it could determine the future accessibility of these substances, which are often used for muscle recovery, inflammation reduction, and overall health improvement. The committee's recommendations, while advisory, could influence the FDA's regulatory approach to these compounds.